dehydroepiandrosterone sulfate has been researched along with Idiopathic Pulmonary Fibrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Funke-Chambour, M; Geiser, TK; Guler, SA; Kocher, G; Machahua, C; Marti, TM; Ryerson, CJ; Tan, B; Trappetti, V | 1 |
Barrera, L; Becerril, C; Chavira, R; Lozano, A; Mendoza-Milla, C; Montaño, M; Morales, V; Pardo, A; Rangel, C; Ruiz, V; Selman, M; Valero Jiménez, A | 1 |
2 other study(ies) available for dehydroepiandrosterone sulfate and Idiopathic Pulmonary Fibrosis
Article | Year |
---|---|
Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study.
Topics: Dehydroepiandrosterone Sulfate; Female; Fibrosis; Humans; Idiopathic Pulmonary Fibrosis; Lung; Lung Diseases, Interstitial; Male | 2022 |
Dehydroepiandrosterone has strong antifibrotic effects and is decreased in idiopathic pulmonary fibrosis.
Topics: Aged; Apoptosis; Bronchoalveolar Lavage; Case-Control Studies; Caspase 9; Cell Differentiation; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Collagen; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Fibroblasts; Gene Expression Profiling; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Platelet-Derived Growth Factor; Transforming Growth Factor beta1 | 2013 |